Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity

Diabetic Medicine

Volumn 15, Issue 1, 1998, Pages 15-24

  Hattersley, A T ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Glucokinase; HNF1 ; HNF4 ; IPF1; MODY; Prediction; Prevention

Indexed keywords

GLUCOKINASE; NUCLEAR FACTOR;

AUTOSOMAL DOMINANT INHERITANCE; CAUCASIAN; DIABETIC ANGIOPATHY; EXERCISE; GENE MUTATION; GENETIC HETEROGENEITY; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MATURITY ONSET DIABETES MELLITUS; MOLECULAR GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; REVIEW;

ADOLESCENT; ADULT; AGE OF ONSET; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHILD; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; GENES, DOMINANT; GENETIC HETEROGENEITY; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PREVALENCE; TRANSCRIPTION FACTORS;

EID: 0031914679     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199801)15:1<15::AID-DIA562>3.0.CO;2-M     Document Type: Review

References (73)

1. Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med 1974; 43: 339-357.
2. Hattersley AT, Turner RC, Permutt MA et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 1992; 339: 1307-1310.
3. Hattersley AT. Maturity-onset diabetes of the young. Baillière's Clinical Paediatrics 1996; 4: 663-680.
4. Froguel P, Vaxillaire M, Sun F et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 162-164.
5. O'Rahilly S, Spivey RS, Holman RR, Nugent Z, Clark A, Turner RC. Type II diabetes of early onset: a distinct clinical and genetic syndrome? Br Med J 1987; 294: 923-928.
6. Hattersley AT. Genetic factors in the aetiology of non-insulin-dependent diabetes. In: Leslie RDG, ed., Molecular Pathogenesis of Diabetes Mellitus, 1st edn. London: Karger, 1997: 157-178.
7. McCarthy MI, Froguel P, Hitman GA. The genetics of non-insulin-dependent diabetes mellitus: tools and aims. Diabetologia 1994; 37: 959-968.
8. Froguel P, Velho G, Passa P, Cohen D. Genetic determinants of type 2 diabetes mellitus: lessons learned from family studies. Diabete et Metabolisme 1993; 19: 1-10.
9. Yamagata K, Oda N, Kaisaki PJ et al. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996; 384: 455-458.
10. Yamagata K, Furuta H, Oda N et al. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384: 458-460.
11. Matschinsky FM. Glucokinase as glucose sensor and mtabolic signal generator in pancreatic β-cell and hepatocytes. Diabetes 1990; 30: 647-752.
12. Tanizawa Y, Matsutani A, Chiu KC, Permutt MA. Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism. Molecular Endocrinology 1992; 6: 1070-1081.
13. Tanizawa Y, Chiu KC, Province MA et al. Two microsatellite repeat polymorphisms flanking opposite ends of the human glucokinase gene: use in haplotype analysis of Welsh Caucasians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 409-413.
14. Vionnet N, Stoffel M, Takeda J et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 721-722.
15. Stoffel M, Froguel P, Takeda J et al. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent. Proc Natl Acad Sci USA 1992; 89: 7698-7702.
16. Stoffel M, Patel P, Lo YM et al. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nature Genetics 1992; 2: 153-156.
17. Froguel P, Zouali H, Vionnet N et al. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 1993; 328: 697-702.
18. Stoffel M, Bell K, Blackburn C et al. Identification of glucokinase mutations in subjects with gestational diabetes mellitus. Diabetes 1993; 42: 937-940.
19. Hager J, Blanche H, Sun F et al. Six mutations in the glucokinase gene identified in MODY by using a nonradioactive sensitive screening technique. Diabetes 1994; 43: 730-733.
20. Velho G, Blanche H, Vaxillaire M et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997; 40: 217-224.
21. Gidh-Jain M, Takeda J, Xu LZ et al. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proc Natl Acad Sci USA 1993; 90: 1932-1936.
22. Hattersley AT. Glucokinase mutations and Type 2 diabetes. In: Lightman S, ed. Horizons in Medicine, vol. 7. Bristol: Blackwell Science, 1996: 440-449.
23. Page RC, Hattersley AT, Levy JC et al. Clinical characteristics of subjects with a missense mutation in glucokinase. Diabetic Med 1995; 12: 209-217.
24. Appleton M, Ellard S, Bulman M, Frayling T, Page R, Hattersley AT. Clinical characteristics of the HNF1α (MODY3) and glucokinase mutations (Abstract). Diabetologia 1997; 40: A161.
25. Jarrett RJ, McCartney P, Keen H. The Bedford Survey: ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 1982; 22: 79-84.
26. Velho G, Froguel P, Clement K et al. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 1992; 340; 444-448.
27. Byrne MM, Sturis J, Clement K et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 1994; 93: 1120-1130.
28. O'Rahilly S, Hattersley A, Vaag A, Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophecy? Lancet 1994; 344: 585-589.
29. Katagiri H, Asano T, Ishihara H et al. Nonsense mutation of glucokinase gene in late-onset non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 1316-1317.
30. Froguel P, Velho C, Cohen D, Passa P. Strategies for the collection of sibling-pair data for genetic studies in type 2 (non-insulin-dependent) diabetes mellitus (Letter). Diabetologia 1991; 34: 685.
31. Saker PJ, Hattersley AT, Barrow B et al. High prevalence of a missense mutation of the glucokinase gene in gestational diabetic patients due to a founder-effect in a local population. Diabetologia 1996; 39: 1325-1328.
32. Chiu KC, Tanizawa Y, Permutt MA. Glucokinase gene variants in the common form of NIDDM. Diabetes 1993; 42: 579-582.
33. Hattersley AT, Turner RC. Mutations of the glucokinase gene and type 2 diabetes. Q J Med 1993; 86: 227-232.
34. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
35. Vaxillaire M, Boccio V, Philippi A et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genetics 1995; 9: 418-423.
36. Dronsfield MJ, Tack CJJ, Bain SC, Hattersley AT. Linkage of the gene for maturity-onset diabetes of the young (MODY) with markers on the long arm of chromosome 12. Diabetologia 1995; 38: 229.
37. Menzel S, Yamagata K, Trabb J et al. Localization of MODY3 to a 5-cM region of human chromosome 12. Diabetes 1995; 44: 1408-1413.
38. Frayling T, Bulman MP, Ellard S et al. Mutations in the hepatocyte nuclear factor 1 alpha gene are a common cause of maturity-onset diabetes of the young in the United Kingdom. Diabetes 1997; 46; 720-725.
39. Kaisaki PJ, Menzel S, Lindner T et al. Mutations in the hepatocyte nuclear factor 1 α gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 1997; 45 528-535.
40. Vaxillaire M, Rouard M, Yamagata K et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity onset diabetes of the young (MODY3). Human Molecular Genetics 1997; 6: 583-586.
41. Hansen T, Eiberg H, Rouard M et al. Novel MODY3 mutations in the hepatic nuclear factor-1α gene. Diabetes 1997; 46: 726-730.
42. Gragnoli C, Lindner T, Marozzi G, Andreani D. Disruption of the HNF-4α promoter in an Italian family with MODY (Abstract). Diabetologia 1997; 40 (suppl 1): A7.
43. Glucksmann MA, Lehto M, Tayber O et al. Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes 1997; 46; 1081-1086.
44. Iwasaki N, Oda N, Ogata M et al. Mutations in the hepatocyte nuclear factor 1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes 1997; 46; 1504-1508.
45. Frayling TM, Bulman MP, Appleton M, Bain SC, Hattersley AT, Ellard S. A rapid screening method for hepatocyte nuclear factor 1 alpha; prevalence in maturity-onset diabetes of the young and late-onset non-insulin dependent diabetes. Human Genetics 1997; in press.
46. Pontoglio M, Barra J, Hadchouel M et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal fanconi syndrome. Cell 1996; 84: 575-585.
47. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nature Genetics 1997; 15: 106-110.
48. Menzel S, Kaisaki P, Menzel R et al. Phenotype of human hepatocyte nuclear factor 1α mutations: diabetes late complications, and glucosuria. Diabtologia 1997; 40: A161.
49. Velho C, Vaxillaire M, Boccio V, Charpentier G, Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q. Diabetes Care 1996; 19: 915-919.
50. Byrne MM, Sturis J, Menzel S et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 1996; 45: 1503-1510.
51. Appleton M, Hattersley AT. Maturity onset diabetes of the young: a missed diagnosis. Diabetic Med 1996; 13 (suppl 2): AP3.
52. Bell GI, Xiang KS, Newman MV et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 1991; 88: 1484-1488.
53. Bulman M, Dronsfield MJ, Frayling T et al. A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia 1997; 40: 859-863.
54. Stoffel M, Vaisse C, Kim J, Duncan SA. Molecular characterisation of the HNF-4αQ268X (MODY1) mutation (Abstract). Diabetes 1997; 6 (suppl 1): 51A.
55. Lindner T, Gragnoli C, Furuta H et al. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4α/MODY1 gene. J Clin Invest 1997; 100: 1400-1405.
56. Moller AM, Urhammer SA, Dalgaard LT et al. Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM. Diabetologia 1997; 40: 980-983.
57. Furuta H, Iwasaki N, Oda N et al. Organization and partial sequence of the hepatocyte nuclear tactor-4α/MODY1 gene and identification of a missense mutation R125W, in a Japanese family with MODY. Diabetes 1997; in press.
58. Fajans SS. Heterogeneity between various families with non-insulin dependent diabetes of the MODY type. In: Kobberling J, Tattersall R, eds. The Genetics of Diabetes Mellitus. London: Academic Press, 1982: 251-601.
59. Fajans SS. MODY: a model for understanding the pathogeneses and natural history of type II diabetes. Hormone and Metabolic Research 1987; 19; 591-599.
60. Fajans SS. Maturity-onset diabetes of the young (MODY). Diabetes Metabolism Revs 1989; 5: 579-606.
61. Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care 1990; 13: 49-64.
62. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS. Maturity-onset diabetes of the young. Life Sciences 1994; 55: 413-422.
63. Fajans SS, Brown MB. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young. Diabetes Care 1993; 16; 1254-1261.
64. Herman WH, Fajans SS, Ortiz FJ et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 1994; 43(1): 40-46. (Published erratum in Diabetes 1994, 43: 1171.)
65. Byrne MM, Sturis J, Fajans SS et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 1995; 44: 699-704.
66. Yamada S, Nishigori H, Onda H et al. Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of late-onset NIDDM in Japanese subjects. Diabetes 1997; 46; 1512-1513.
67. Urhammer SA, Rasmussen SK, Kaisaki PJ et al. Genetic variation in the hepatocyte nuclear factor-1α gene in Danish Caucasians with late onset NIDDM. Diabetologia 1997; 40: 473-475.
68. Mahtani M, Widen E, Lehto M et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genetics 1996; 14: 90-94.
69. Ji L, Malecki M, Warram HJ, Yang Y, Rich SS, Krolewski AS. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997; 46: 876-881.
70. Bowden WD, Sale M, Howard TD et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 1997; 46: 882-886.
71. Zouali H, Hani EH, Philippi A et al. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 1997; 6: 1401-1408.
72. Hattersley AT, Appleton M, Smith SM et al. Hepatic nuclear factor 1α mutations result in beta-cell dysfunction. Diabetologia 1997; 40: A162.
73. Stoffers DA, Ferrer J, Clarke WE, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genetics 1997; 17: 138-139.